RARX - Ra Pharmaceuticals Inc

Exchange: NASDAQ

RARX - Ra Pharmaceuticals Inc

Exchange: NASDAQ
#1112()/6981

Fri 20'th Jul 2018

PERIOD 2018-04-23 - 2018-07-20
CHANGE 2.10%
PRICE $11.17
VOLUME
Buy
TREND
Buy

MV LONG
Buy

MV SHORT
Sell

PIVOT
Buy

MACD
Sell

Request Prediction
0.00%
Predict

Ra Pharmaceuticals Inc Stock Analysis

Technical stock analysis for Fri 20'th Jul 2018

Buy candidate since 2018-07-19 Gain 2.10%
Shorts 2.71% ( 2018-06-29 )
Cash 180.7 mill
Loans n/a
Beta 1.86
ROA -47.43

Ra Pharmaceuticals Inc gained 2.10% in the last trading day, rising from $10.94 to $11.17 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has been going up and down for this period, and there has been a 6.38% gain for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 74 457 more shares were traded than the day before. In total, 199 986 shares bought and sold for approximately $2.23 million.

Trend

Ra Pharmaceuticals Inc lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 104.62% during the next 3 months and, with 90% probability hold a price between $21.34 and $26.03 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. Ra Pharmaceuticals Inc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $11.20. On a fall, the stock will find some support from the long-term average at approximately $9.62. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Wednesday July 18, 2018, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 59 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $9.95 and $9.42.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Ra Pharmaceuticals Inc finds support just below today's level at $9.95. If this is broken, then the next support from accumulated volume will be at $9.42 and $9.16.

Support: $9.95 Price: $11.17 Resistance: $11.18

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.76 between high and low, or 7.09%. For the last week, the stock has had a daily average volatility of 7.19%.

Our recommended stoploss: $10.65 (-4.69%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 2 days ago.)

Overall risk:

Very Low Low Medium High Very High

RARX $11.17 $0.23(2.10%)
RARX is up $0.23 today, but where's it headed in August?
Zacks Investment Research is releasing its prediction for RARX based on the 1-3 month system that more than doubles the S&P 500.

Click here – the RARX analysis is free »
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at


in partnership with
START FREE 5-DAY TRIAL